switching between glp-1 agonists ada Comparing Ozempic, Wegovy and Other Drugs #4 NN Clinical Use
Description
Figure 1 supplementary Fig 4: Design of the peptide I-M-150846 A
Bytzer P, Talley NJ, Leemon M, et al

Whether continued GCGR-mediated energy expenditure explains the sustained trajectory is not yet formally characterised, but the mechanistic hypothesis is consistent with the animal data

Using large language models to assess public perceptions around glucagon-like peptide-1 receptor agonists on social media

Think about your health, weight goals and lifestyle

These medications slow gastric emptying to improve blood sugar control and promote weight loss, but this same mechanism may contribute to reflux symptoms